Stark DME hearing
This article was originally published in The Gray Sheet
Executive SummaryRep. Pete Stark (D-Calif.), chairman of the House Ways and Means health subcommittee, plans April 14 hearing to address "issues relating to clinical laboratory services and durable medical equipment," according to a March 26 press release. The subcommittee points out that the Congressional Budget Office has estimated that President Clinton's fiscal year 1994 budget proposal ("The Gray Sheet" Feb. 22, p. 1) includes provisions that would reduce payments for DME by $651 mil. over five years. Stark recently introduced legislation (H.R. 1255) aimed at preventing DME-related fraud and abuse.
You may also be interested in...
Senate Finance Committee’s approach to penalize companies for raising WAC list prices is not a ‘price control,’ but a reasonable approach to change the incentives that distort pricing in the supply chain, US HHS Secretary Alex Azar says.
With the pre-GDUFA backlog largely acted upon, the FDA expects ANDA approvals to decrease, but supplement actions to increase in FY 2020 and FY 2021.
February and March inspections deferred unless any are deemed mission critical. China director remains behind as staff evacuate.